Pharmosa Biopharm Inc. (TPEX:6875)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.05
-0.45 (-1.11%)
At close: Feb 26, 2026
-31.77%
Market Cap 5.17B
Revenue (ttm) 136.72M
Net Income (ttm) -237.74M
Shares Out 129.09M
EPS (ttm) -1.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 212,036
Average Volume 208,888
Open 38.25
Previous Close 40.50
Day's Range 38.25 - 40.70
52-Week Range 37.00 - 65.00
Beta 0.33
RSI 21.79
Earnings Date Mar 6, 2026

About Pharmosa Biopharm

Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei, Taiwan... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6875
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.